Prochlorperazine - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for prochlorperazine and what is the scope of patent protection?
Prochlorperazine
is the generic ingredient in six branded drugs marketed by Glaxosmithkline, Padagis Us, Able, Cosette, Alpharma Us Pharms, Morton Grove, Baxter Hlthcare, Amneal, Avet Lifesciences, Caplin, Eugia Pharma, Gland Pharma Ltd, Hikma, Hospira, Marsam Pharms Llc, Mylan Labs Ltd, Nexus, Sagent, Smith And Nephew, Somerset Theraps Llc, Teva Parenteral, Viwit Pharm, Watson Labs, Wyeth Ayerst, Ajanta Pharma Ltd, Bionpharma, Chartwell Rx, Duramed Pharms Barr, Glenmark Pharms Ltd, Ivax Sub Teva Pharms, Leading, Norvium Bioscience, Novitium Pharma, Teva Pharms, Zydus Lifesciences, and Jubilant Cadista, and is included in fifty-five NDAs. Additional information is available in the individual branded drug profile pages.There are twenty-one drug master file entries for prochlorperazine. Three suppliers are listed for this compound.
Summary for prochlorperazine
US Patents: | 0 |
Tradenames: | 6 |
Applicants: | 36 |
NDAs: | 55 |
Drug Master File Entries: | 21 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Clinical Trials: | 50 |
Patent Applications: | 6,770 |
Drug Prices: | Drug price trends for prochlorperazine |
Drug Sales Revenues: | Drug sales revenues for prochlorperazine |
What excipients (inactive ingredients) are in prochlorperazine? | prochlorperazine excipients list |
DailyMed Link: | prochlorperazine at DailyMed |
Recent Clinical Trials for prochlorperazine
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Washington University School of Medicine | Phase 2 |
Assertio Holdings, Inc | Phase 2 |
Dayton Children's Hospital | N/A |
Pharmacology for prochlorperazine
Drug Class | Phenothiazine |
Medical Subject Heading (MeSH) Categories for prochlorperazine
Anatomical Therapeutic Chemical (ATC) Classes for prochlorperazine
US Patents and Regulatory Information for prochlorperazine
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alpharma Us Pharms | PROCHLORPERAZINE | prochlorperazine edisylate | CONCENTRATE;ORAL | 087153-001 | Jun 8, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Zydus Lifesciences | PROCHLORPERAZINE MALEATE | prochlorperazine maleate | TABLET;ORAL | 216495-001 | Aug 8, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Glaxosmithkline | COMPAZINE | prochlorperazine maleate | CAPSULE, EXTENDED RELEASE;ORAL | 011000-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Glaxosmithkline | COMPAZINE | prochlorperazine maleate | CAPSULE, EXTENDED RELEASE;ORAL | 011000-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.